Bryan King, MD, MBA
Professor
Psychiatry
School of Medicine

My research and clinical work has largely focused on psychiatric aspects of developmental disorders, and upon the pathogenesis and treatment of significant behavioral disturbance in autism and related disorders in particular. In recent years, this focus has been primarily directed on interventions in autism including both pharmacological and psychosocial treatments.

Awards

Show all (13) Hide

• Fellow, American Psychiatric Association, 2015
• Beta Gamma Sigma International Business Honor Society, George Washington University School of Business, 2014
• Distinguished Fellow, American Academy of Child and Adolescent Psychiatry, 2011
• Annual Family Choice Award, Seattle Children's Hospital Family Advisory Council, 2007
• Frank J. Menolascino Award, American Psychiatric Association, 2001
• Outstanding Physician Award, UCLA Neuropsychiatric Institute Department of Nursing, 1997
• Outstanding Mentor Award, UCLA Neuropsychiatric Institute Department of Psychiatry, 1997
• George Tarjan Award, American Academy of Child and Adolescent Psychiatry, 1990
• Individual Research Service Award, NIMH, 1988
• Gertrude Rogers Greenblatt Fellowship, UCLA Neuropsychiatric Institute, 1988
• Honors in Research, UC Irvine, 1979
• Magna Cum Laude, UC Irvine, 1979
• Phi Beta Kappa, UC Irvine, 1979

Education & Training

Show all (7) Hide

• Diversity, Equity, and Inclusion Champion Training University of California 2018
• MBA Business George Washington University 2014
• Fellowship in Child and Adolescent Psychiatry Psychiatry UCLA Neuropsychiatric Institute 1990
• Residency in Psychiatry Psychiatry UCLA Neuropsychiatric Institute 1987
• Internship Internal Medicine UCLA Center for Health Sciences 1984
• MD Medicine Medical College of Wisconsin 1983
• BS Biological Sciences University of California, Irvine 1979

Grants and Projects

Show all (5) Hide

• 2/4-RUPP Autism Network: Guanfacine for the Treatment of Hyperactivity in PDD, NIH, 2010-2014
• UW Autism Center of Excellence, NIH, 2007-2013
• Self Injurious Behavior in Mental Retardation, NIH, 1996-2001
• Serotonergic Mechanisms and Self-injurious Behavior, NIH, 1991-1997
• Serotonin Receptor Function &Child Psychopathology, NIH, 1989-1900

Publications (154)

Top publication keywords:
Asperger SyndromeChild Development Disorders, PervasiveCitalopramPsychotropic DrugsTuberous SclerosisIntellectual DisabilityPsychologyMental DisordersGABA-B Receptor AgonistsDiagnostic and Statistical Manual of Mental DisordersAutism Spectrum DisorderChild Behavior DisordersSelf-Injurious BehaviorBaclofenAutistic Disorder

• The Human Phenotype Ontology in 2024: phenotypes around the world.
  Nucleic acids research 2024 Gargano MA, Matentzoglu N, Coleman B, Addo-Lartey EB, Anagnostopoulos AV, Anderton J, Avillach P, Bagley AM, Bakštein E, Balhoff JP, Baynam G, Bello SM, Berk M, Bertram H, Bishop S, Blau H, Bodenstein…
• Diagnosis and Management of Comorbidities in ASD.
  Journal of the American Academy of Child & Adolescent Psychiatry 2023 Alice R. Mao, Olivia Hindera, Bryan H. King
• Autism Spectrum Disorder: A Review.
  JAMA 2023 Hirota T, King BH
• Genetic and epigenetic signatures associated with plasma oxytocin levels in children and adolescents with autism spectrum disorder.
  Autism research : official journal of the International Society for Autism Research 2023 Siecinski SK, Giamberardino SN, Spanos M, Hauser AC, Gibson JR, Chandrasekhar T, Trelles MDP, Rockhill CM, Palumbo ML, Cundiff AW, Montgomery A, Siper P, Minjarez M, Nowinski LA, Marler S, Kwee LC, …
• Adaptive Behavior in Young Autistic Children: Associations with Irritability and ADHD Symptoms.
  Journal of autism and developmental disorders 2022 Carpenter KLH, Davis NO, Spanos M, Sabatos-DeVito M, Aiello R, Baranek GT, Compton SN, Egger HL, Franz L, Kim SJ, King BH, Kolevzon A, McDougle CJ, Sanders K, Veenstra-VanderWeele J, Sikich L, Kollins…

Show all (149 more) Hide

• A MULTIDIMENSIONAL APPROACH TO MANAGING MOOD AND BEHAVIOR IN ASD.
  Journal of the American Academy of Child & Adolescent Psychiatry 2022 Alice R. Mao, Olivia Hindera, Bryan H. King
• AN UPDATE ON COMMON COMORBIDITIES IN ASD: SLEEP DISORDERS, ANXIETY, BODY-FOCUSED REPETITIVE BEHAVIORS, AND IRRITABILITY.
  Journal of the American Academy of Child & Adolescent Psychiatry 2022 Christopher J. McDougle, Robyn P. Thom, Bryan H. King
• Citalopram Did Not Significantly Improve Anxiety in Children with Autism Spectrum Disorder Undergoing Treatment for Core Symptoms: Secondary Analysis of a Trial to Reduce Repetitive Behaviors.
  Journal of child and adolescent psychopharmacology 2022 Simonoff E, Mowlem F, Pearson O, Anagnostou E, Donnelly C, Hollander E, King BH, McCracken JT, Scahill L, Sikich L, Pickles A
• Adolescents With Eating Disorders in Pediatric Practice - The European Academy of Paediatrics Recommendations.
  Frontiers in pediatrics 2022 Rynkiewicz A, Dembinski L, Koletzko B, Michaud PA, Hadjipanayis A, Grossman Z, Korslund K, King BH, Treasure J, Peregud-Pogorzelski J, Del Torso S, Valiulis A, Mazur A
• Intranasal Oxytocin in Children and Adolescents with Autism Spectrum Disorder.
  The New England journal of medicine 2021 Sikich L, Kolevzon A, King BH, McDougle CJ, Sanders KB, Kim SJ, Spanos M, Chandrasekhar T, Trelles MDP, Rockhill CM, Palumbo ML, Witters Cundiff A, Montgomery A, Siper P, Minjarez M, Nowinski LA, …
• AUTISM SPECTRUM DISORDER: MANAGEMENT OF SEVERE BEHAVIORAL AND MOOD DISORDERS.
  Journal of the American Academy of Child & Adolescent Psychiatry 2021 Alice R. Mao, Ashok P. Yerramsetti, Bryan H. King
• Predictors of Caregiver Strain for Parents of Children with Autism Spectrum Disorder.
  Journal of autism and developmental disorders 2021 Bradshaw J, Gillespie S, McCracken C, King BH, McCracken JT, Johnson CR, Lecavalier L, Smith T, Swiezy N, Bearss K, Sikich L, Donnelly C, Hollander E, McDougle CJ, Scahill L
• Olanzapine.
  2021 Brett Yamane, L. Lee Carlisle, Bryan King
• Gender Differences in Treatment-Seeking Youth with Autism Spectrum Disorder.
  Journal of Child and Family Studies 2021 Tom Cariveau, Courtney E. McCracken, Jessica Bradshaw, Valentina Postorino, M. Alice Shillingsburg, Christopher J. McDougle, Michael G. Aman, James T. McCracken, Elaine Tierney, Cynthia Johnson, Luc …
• AUTISM SPECTRUM DISORDER: MANAGING AGGRESSION, AFFECTIVE LABILITY, SELF-INJURIOUS BEHAVIOR, AND SUICIDALITY IN THE OUTPATIENT SETTING.
  Journal of the American Academy of Child & Adolescent Psychiatry 2020 Alice R. Mao, Nancy C. Shenoi, Bryan H. King
• NEUROGENETIC SYNDROMES ASSOCIATED WITH AUTISM SPECTRUM DISORDER.
  Journal of the American Academy of Child & Adolescent Psychiatry 2020 Robyn P. Thom, Christopher J. McDougle, Bryan H. King
• Rationale, design, and methods of the Autism Centers of Excellence (ACE) network Study of Oxytocin in Autism to improve Reciprocal Social Behaviors (SOARS-B).
  Contemporary clinical trials 2020 Spanos M, Chandrasekhar T, Kim SJ, Hamer RM, King BH, McDougle CJ, Sanders KB, Gregory SG, Kolevzon A, Veenstra-VanderWeele J, Sikich L
• A Model for Addressing Crisis Behavior in Youth With Autism Spectrum Disorder Within a Functional and Contextual Framework.
  2020 Bryan H. King, Agnieszka Rynkiewicz, Malgorzata Janas-Kozik, Marta Tyszkiewicz-Nwafor
• Practice Parameter for the Assessment and Treatment of Psychiatric Disorders in Children and Adolescents With Intellectual Disability (Intellectual Developmental Disorder).
  Journal of the American Academy of Child and Adolescent Psychiatry 2019 Siegel M, McGuire K, Veenstra-VanderWeele J, Stratigos K, King B, American Academy of Child and Adolescent Psychiatry (AACAP) Committee on Quality Issues (CQI), Bellonci C, Hayek M, Keable H, Rockhill…
• Fluoxetine and Repetitive Behaviors in Children and Adolescents With Autism Spectrum Disorder.
  JAMA 2019 King BH
• COMPLEX PRESENTATIONS OF ASD: BEYOND THE CORE FEATURES.
  Journal of the American Academy of Child & Adolescent Psychiatry 2019 Amandeep Jutla, Bryan H. King, James T. McCracken
• OUTPATIENT MANAGEMENT OF IRRITABILITY, IMPULSIVE AGGRESSION, AND OTHER SEVERE BEHAVIORS IN YOUTH WITH ASD.
  Journal of the American Academy of Child & Adolescent Psychiatry 2019 Alice R. Mao, Ashok P. Yerramsetti, Bryan H. King
• Overemphasis of the Autism Diagnostic Observation Schedule (ADOS) Evaluation Subverts a Clinician's Ability to Provide Access to Autism Services.
  Journal of the American Academy of Child and Adolescent Psychiatry 2019 Gwynette MF, McGuire K, Fadus MC, Feder JD, Koth KA, King BH
• Developmental social vulnerability as the intrinsic origin of psychopathology: A paradigm shift from disease entities to psychiatric derivatives within human diversity.
  Medical hypotheses 2019 Morioka H, Ijichi S, Ijichi N, Ijichi Y, King BH
• An Observational Study With the Janssen Autism Knowledge Engine (JAKE®) in Individuals With Autism Spectrum Disorder.
  Frontiers in neuroscience 2019 Ness SL, Bangerter A, Manyakov NV, Lewin D, Boice M, Skalkin A, Jagannatha S, Chatterjee M, Dawson G, Goodwin MS, Hendren R, Leventhal B, Shic F, Frazier JA, Janvier Y, King BH, Miller JS, Smith CJ, …
• An exploration of concomitant psychiatric disorders in children with autism spectrum disorder.
  Comprehensive psychiatry 2018 Lecavalier L, McCracken CE, Aman MG, McDougle CJ, McCracken JT, Tierney E, Smith T, Johnson C, King B, Handen B, Swiezy NB, Eugene Arnold L, Bearss K, Vitiello B, Scahill L
• A randomized, placebo-controlled trial of extended-release guanfacine in children with autism spectrum disorder and ADHD symptoms: an analysis of secondary outcome measures.
  Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology 2018 Politte LC, Scahill L, Figueroa J, McCracken JT, King B, McDougle CJ
• Autism spectrum disorder: Consensus guidelines on assessment, treatment and research from the British Association for Psychopharmacology.
  Journal of psychopharmacology (Oxford, England) 2017 Howes OD, Rogdaki M, Findon JL, Wichers RH, Charman T, King BH, Loth E, McAlonan GM, McCracken JT, Parr JR, Povey C, Santosh P, Wallace S, Simonoff E, Murphy DG
• 21.0 Inpatient Treatment of Children With Autism and Intellectual Disability: Three Innovative Models.
  Journal of the American Academy of Child & Adolescent Psychiatry 2017 Matthew Siegel, Bryan H. King
• Disruption to control network function correlates with altered dynamic connectivity in the wider autism spectrum.
  NeuroImage. Clinical 2017 de Lacy N, Doherty D, King BH, Rachakonda S, Calhoun VD
• Association Between Maternal Use of SSRI Medications and Autism in Their Children.
  JAMA 2017 King BH
• Arbaclofen in Children and Adolescents with Autism Spectrum Disorder: A Randomized, Controlled, Phase 2 Trial.
  Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology 2016 Veenstra-VanderWeele J, Cook EH, King BH, Zarevics P, Cherubini M, Walton-Bowen K, Bear MF, Wang PP, Carpenter RL
• 4.6 Updates on Co-Occurring Conditions With Neurodevelopmental Disorders: Recognition and Treatment.
  Journal of the American Academy of Child & Adolescent Psychiatry 2016 Bryan H. King
• 7.2 Diagnostic Assessment for Autism Spectrum Disorder.
  Journal of the American Academy of Child & Adolescent Psychiatry 2016 Bryan H. King
• Autism Spectrum Disorder: From Clinical Assessment to Novel Treatments.
  Journal of the American Academy of Child & Adolescent Psychiatry 2016 Alexander Kolevzon, Bryan H. King
• Severity of ASD symptoms and their correlation with the presence of copy number variations and exposure to first trimester ultrasound.
  Autism research : official journal of the International Society for Autism Research 2016 Webb SJ, Garrison MM, Bernier R, McClintic AM, King BH, Mourad PD
• Psychiatric comorbidities in neurodevelopmental disorders.
  Current opinion in neurology 2016 King BH
• Assessing Risk of Autism Spectrum Disorder in Children After Antidepressant Use During Pregnancy.
  JAMA pediatrics 2016 King BH
• Unequal Individual Risk and Potential Benefit Balanced by Benefits to the Population at Large in Autism Clinical Trials?
  The American journal of bioethics : AJOB 2016 Stein MA, King BH
• Focus on Autism and Related Conditions.
  Focus (American Psychiatric Publishing) 2015 Yu C, King BH
• Children with autism spectrum disorder and social skills groups at school: a randomized trial comparing intervention approach and peer composition.
  Journal of child psychology and psychiatry, and allied disciplines 2015 Kasari C, Dean M, Kretzmann M, Shih W, Orlich F, Whitney R, Landa R, Lord C, King B
• Extended-Release Guanfacine for Hyperactivity in Children With Autism Spectrum Disorder.
  The American journal of psychiatry 2015 Scahill L, McCracken JT, King BH, Rockhill C, Shah B, Politte L, Sanders R, Minjarez M, Cowen J, Mullett J, Page C, Ward D, Deng Y, Loo S, Dziura J, McDougle CJ, Research Units on Pediatric …
• The relationship between treatment attendance, adherence, and outcome in a caregiver-mediated intervention for low-resourced families of young children with autism spectrum disorder.
  Autism : the international journal of research and practice 2015 Carr T, Shih W, Lawton K, Lord C, King B, Kasari C
• Factor structure and psychometric properties of the revised Home Situations Questionnaire for autism spectrum disorder: The Home Situations Questionnaire-Autism Spectrum Disorder.
  Autism : the international journal of research and practice 2015 Chowdhury M, Aman MG, Lecavalier L, Smith T, Johnson C, Swiezy N, McCracken JT, King B, McDougle CJ, Bearss K, Deng Y, Scahill L
• Promising forecast for autism spectrum disorders.
  JAMA 2015 King BH
• TET1 is a tumor suppressor of hematopoietic malignancy.
  Nature immunology 2015 Cimmino L, Dawlaty MM, Ndiaye-Lobry D, Yap YS, Bakogianni S, Yu Y, Bhattacharyya S, Shaknovich R, Geng H, Lobry C, Mullenders J, King B, Trimarchi T, Aranda-Orgilles B, Liu C, Shen S, Verma AK, …
• Tuberous sclerosis associated neuropsychiatric disorders (TAND) and the TAND Checklist.
  Pediatric neurology 2014 de Vries PJ, Whittemore VH, Leclezio L, Byars AW, Dunn D, Ess KC, Hook D, King BH, Sahin M, Jansen A
• Contrasting roles of histone 3 lysine 27 demethylases in acute lymphoblastic leukaemia.
  Nature 2014 Ntziachristos P, Tsirigos A, Welstead GG, Trimarchi T, Bakogianni S, Xu L, Loizou E, Holmfeldt L, Strikoudis A, King B, Mullenders J, Becksfort J, Nedjic J, Paietta E, Tallman MS, Rowe JM, Tonon G, …
• The peer relationships of girls with ASD at school: comparison to boys and girls with and without ASD.
  Journal of child psychology and psychiatry, and allied disciplines 2014 Dean M, Kasari C, Shih W, Frankel F, Whitney R, Landa R, Lord C, Orlich F, King B, Harwood R
• Caregiver-mediated intervention for low-resourced preschoolers with autism: an RCT.
  Pediatrics 2014 Kasari C, Lawton K, Shih W, Barker TV, Landa R, Lord C, Orlich F, King B, Wetherby A, Senturk D
• Measuring anxiety as a treatment endpoint in youth with autism spectrum disorder.
  Journal of autism and developmental disorders 2014 Lecavalier L, Wood JJ, Halladay AK, Jones NE, Aman MG, Cook EH, Handen BL, King BH, Pearson DA, Hallett V, Sullivan KA, Grondhuis S, Bishop SL, Horrigan JP, Dawson G, Scahill L
• Sunsetting DSM-IV's pervasive developmental disorder.
  Journal of the American Academy of Child and Adolescent Psychiatry 2014 King BH
• STX209 (arbaclofen) for autism spectrum disorders: an 8-week open-label study.
  Journal of autism and developmental disorders 2014 Erickson CA, Veenstra-Vanderweele JM, Melmed RD, McCracken JT, Ginsberg LD, Sikich L, Scahill L, Cherubini M, Zarevics P, Walton-Bowen K, Carpenter RL, Bear MF, Wang PP, King BH
• Update on diagnostic classification in autism.
  Current opinion in psychiatry 2014 King BH, Navot N, Bernier R, Webb SJ
• Side effects from use of one or more psychiatric medications in a population-based sample of children and adolescents.
  Journal of child and adolescent psychopharmacology 2014 Hilt RJ, Chaudhari M, Bell JF, Wolf C, Koprowicz K, King BH
• Practice parameter for the assessment and treatment of children and adolescents with autism spectrum disorder.
  Journal of the American Academy of Child and Adolescent Psychiatry 2014 Volkmar F, Siegel M, Woodbury-Smith M, King B, McCracken J, State M, American Academy of Child and Adolescent Psychiatry (AACAP) Committee on Quality Issues (CQI)
• Community child psychiatric medication experiences measured by an internet-based, prospective parent survey of retail pharmacy customers.
  Community mental health journal 2013 Hilt R, Wolf C, Koprowicz K, Thomas E, Chandler M, Hao XL, Russell M, Le T, Hooks L, King B
• Measuring repetitive behaviors as a treatment endpoint in youth with autism spectrum disorder.
  Autism : the international journal of research and practice 2013 Scahill L, Aman MG, Lecavalier L, Halladay AK, Bishop SL, Bodfish JW, Grondhuis S, Jones N, Horrigan JP, Cook EH, Handen BL, King BH, Pearson DA, McCracken JT, Sullivan KA, Dawson G
• Mice exposed to diagnostic ultrasound in utero are less social and more active in social situations relative to controls.
  Autism research : official journal of the International Society for Autism Research 2013 McClintic AM, King BH, Webb SJ, Mourad PD
• Baseline factors predicting placebo response to treatment in children and adolescents with autism spectrum disorders: a multisite randomized clinical trial.
  JAMA pediatrics 2013 King BH, Dukes K, Donnelly CL, Sikich L, McCracken JT, Scahill L, Hollander E, Bregman JD, Anagnostou E, Robinson F, Sullivan L, Hirtz D
• Children's Yale-Brown obsessive compulsive scale in autism spectrum disorder: component structure and correlates of symptom checklist.
  Journal of the American Academy of Child and Adolescent Psychiatry 2013 Scahill L, Dimitropoulos A, McDougle CJ, Aman MG, Feurer ID, McCracken JT, Tierney E, Pu J, White S, Lecavalier L, Hallett V, Bearss K, King B, Arnold LE, Vitiello B
• Training of child and adolescent psychiatry fellows in autism and intellectual disability.
  Autism : the international journal of research and practice 2013 Marrus N, Veenstra-Vanderweele J, Hellings JA, Stigler KA, Szymanski L, King BH, Carlisle LL, Cook EH, American Academy of Child Adolescent Psychiatry (AACAP) Autism and Intellectual Disability …
• Exploring the manifestations of anxiety in children with autism spectrum disorders.
  Journal of autism and developmental disorders 2013 Hallett V, Lecavalier L, Sukhodolsky DG, Cipriano N, Aman MG, McCracken JT, McDougle CJ, Tierney E, King BH, Hollander E, Sikich L, Bregman J, Anagnostou E, Donnelly C, Katsovich L, Dukes K, Vitiello …
• Tuberous sclerosis complex diagnostic criteria update: recommendations of the 2012 Iinternational Tuberous Sclerosis Complex Consensus Conference.
  Pediatric neurology 2013 Northrup H, Krueger DA, International Tuberous Sclerosis Complex Consensus Group
• Tuberous sclerosis complex surveillance and management: recommendations of the 2012 International Tuberous Sclerosis Complex Consensus Conference.
  Pediatric neurology 2013 Krueger DA, Northrup H, International Tuberous Sclerosis Complex Consensus Group
• Autism and developmental disorders: management of serious behavioral disturbance.
  Child and adolescent psychiatric clinics of North America 2013 Siegel M, King BH
• Psychiatric assessment of severe presentations in autism spectrum disorders and intellectual disability.
  Child and adolescent psychiatric clinics of North America 2013 King BH, de Lacy N, Siegel M
• Outcome measures for clinical trials in fragile X syndrome.
  Journal of developmental and behavioral pediatrics : JDBP 2013 Berry-Kravis E, Hessl D, Abbeduto L, Reiss AL, Beckel-Mitchener A, Urv TK, Outcome Measures Working Groups
• DSM-5 and autism: kicking the tires and making the grade.
  Journal of the American Academy of Child and Adolescent Psychiatry 2013 King BH, Veenstra-Vanderweele J, Lord C
• Fear-potentiated startle response is unrelated to social or emotional functioning in adolescents with autism spectrum disorders.
  Autism research : official journal of the International Society for Autism Research 2013 Sterling L, Munson J, Estes A, Murias M, Webb SJ, King B, Dawson G
• Olanzapine.
  2013 Brett Yamane, L. Lee Carlisle, Bryan King
• Revisiting the relationship between autism and schizophrenia: toward an integrated neurobiology.
  Annual review of clinical psychology 2013 de Lacy N, King BH
• Consensus paper: pathological role of the cerebellum in autism.
  Cerebellum (London, England) 2012 Fatemi SH, Aldinger KA, Ashwood P, Bauman ML, Blaha CD, Blatt GJ, Chauhan A, Chauhan V, Dager SR, Dickson PE, Estes AM, Goldowitz D, Heck DH, Kemper TL, King BH, Martin LA, Millen KJ, Mittleman G, …
• Commentary from the DSM-5 Workgroup on Neurodevelopmental Disorders.
  Journal of the American Academy of Child and Adolescent Psychiatry 2012 Swedo SE, Baird G, Cook EH, Happé FG, Harris JC, Kaufmann WE, King BH, Lord CE, Piven J, Rogers SJ, Spence SJ, Wetherby A, Wright HH
• Intellectual Disability (Mental Retardation).
  Clinical Child Psychiatry 2012 L. Lee Carlisle, Bryan H. King, Arthur Maerlender
• Design and subject characteristics in the federally-funded citalopram trial in children with pervasive developmental disorders.
  Journal of autism and developmental disorders 2012 Scahill L, McCracken JT, Bearss K, Robinson F, Hollander E, King B, Bregman J, Sikich L, Dukes K, Sullivan L, Anagnostou E, Donnelly C, Kim YS, Ritz L, Hirtz D, Wagner A
• Reduced transcript expression of genes affected by inherited and de novo CNVs in autism.
  European journal of human genetics : EJHG 2011 Nord AS, Roeb W, Dickel DE, Walsh T, Kusenda M, O'Connor KL, Malhotra D, McCarthy SE, Stray SM, Taylor SM, Sebat J, STAART Psychopharmacology Network, King B, King MC, McClellan JM
• Is schizophrenia on the autism spectrum?
  Brain research 2010 King BH, Lord C
• The association between short and long nocturnal sleep durations and risky behaviours and the moderating factors in Taiwanese adolescents.
  Psychiatry research 2010 Yen CF, King BH, Tang TC
• Factor structure of the Athens Insomnia Scale and its associations with demographic characteristics and depression in adolescents.
  Journal of sleep research 2009 Yen CF, King BH, Chang YP
• Lack of efficacy of citalopram in children with autism spectrum disorders and high levels of repetitive behavior: citalopram ineffective in children with autism.
  Archives of general psychiatry 2009 King BH, Hollander E, Sikich L, McCracken JT, Scahill L, Bregman JD, Donnelly CL, Anagnostou E, Dukes K, Sullivan L, Hirtz D, Wagner A, Ritz L, STAART Psychopharmacology Network
• JunB protects against myeloid malignancies by limiting hematopoietic stem cell proliferation and differentiation without affecting self-renewal.
  Cancer cell 2009 Santaguida M, Schepers K, King B, Sabnis AJ, Forsberg EC, Attema JL, Braun BS, Passegué E
• Pharmacology and genetics of autism: implications for diagnosis and treatment.
  Personalized medicine 2008 Brkanac Z, Raskind WH, King BH
• Asperger's syndrome: diagnosis and treatment.
  The American journal of psychiatry 2008 Toth K, King BH
• An update on pharmacologic treatments for autism spectrum disorders.
  Child and adolescent psychiatric clinics of North America 2006 King BH, Bostic JQ
• Mental Retardation.
  Clinical Child Psychiatry, Second Edition 2005 Bryan H. King, Matthew W. State, Arthur Maerlender
• Autism spectrum disorders: emerging pharmacotherapy.
  Expert opinion on emerging drugs 2005 Bostic JQ, King BH
• Consensus clinical guidelines for the assessment of cognitive and behavioural problems in Tuberous Sclerosis.
  European child & adolescent psychiatry 2005 de Vries P, Humphrey A, McCartney D, Prather P, Bolton P, Hunt A, TSC Behaviour Consensus Panel
• Impact of recent findings on study design of future autism clinical trials.
  CNS spectrums 2004 Hollander E, Phillips A, King BH, Guthrie D, Aman MG, Law P, Owley T, Robinson R
• International Review of Research in Mental Retardation
  The role of the basal ganglia in the expression of stereotyped, self-injurious behaviors in developmental disorders. 2004 Cromwell HC, King BH
• Outcome measures for clinical drug trials in autism.
  CNS spectrums 2004 Aman MG, Novotny S, Samango-Sprouse C, Lecavalier L, Leonard E, Gadow KD, King BH, Pearson DA, Gernsbacher MA, Chez M
• The Role of the Basal Ganglia in the Expression of Stereotyped, Self-Injurious Behaviors in Developmental Disorders.
  _categories":[{"id":"closed 2004 Howard C. Cromwell, Bryan H. King
• Asperger syndrome: to be or not to be?
  Current opinion in pediatrics 2003 Foster B, King BH
• Maladaptive behaviour in children and adolescents with Down's syndrome.
  Journal of intellectual disability research : JIDR 2002 Dykens EM, Shah B, Sagun J, Beck T, King BH
• Psychopharmacology in mental retardation.
  Current Opinion in Psychiatry 2002 Bryan H. King
• The quality of health care for adults with developmental disabilities.
  Public health reports (Washington, D.C. : 1974) 2002 Lewis MA, Lewis CE, Leake B, King BH, Lindemann R
• Treatment of pain in acutely burned children.
  The Journal of burn care & rehabilitation 2002 Stoddard FJ, Sheridan RL, Saxe GN, King BS, King BH, Chedekel DS, Schnitzer JJ, Martyn JA
• Pharmacotherapy in mental retardation
  Current Opinion in Psychiatry 2002 King BH
• Autism spectrum disorders: update of evaluation and treatment.
  Current psychiatry reports 2001 Mikhail AG, King BH
• Self-injurious behavior in mental retardation.
  Current Opinion in Psychiatry 2001 Ashraf G. Mikhail, Bryan H. King
• Case series: amantadine open-label treatment of impulsive and aggressive behavior in hospitalized children with developmental disabilities.
  Journal of the American Academy of Child and Adolescent Psychiatry 2001 King BH, Wright DM, Snape M, Dourish CT
• Double-blind, placebo-controlled study of amantadine hydrochloride in the treatment of children with autistic disorder.
  Journal of the American Academy of Child and Adolescent Psychiatry 2001 King BH, Wright DM, Handen BL, Sikich L, Zimmerman AW, McMahon W, Cantwell E, Davanzo PA, Dourish CT, Dykens EM, Hooper SR, Jaselskis CA, Leventhal BL, Levitt J, Lord C, Lubetsky MJ, Myers SM, Ozonoff…
• Self-injurious behavior: gene-brain-behavior relationships.
  Mental retardation and developmental disabilities research reviews 2001 Schroeder SR, Oster-Granite ML, Berkson G, Bodfish JW, Breese GR, Cataldo MF, Cook EH, Crnic LS, DeLeon I, Fisher W, Harris JC, Horner RH, Iwata B, Jinnah HA, King BH, Lauder JM, Lewis MH, Newell K, …
• Self-injurious behaviour in mental retardation
  Current Opinion in Psychiatry 2001 Mikhail AG, King BH
• Pharmacological treatment of mood disturbances, aggression, and self-injury in persons with pervasive developmental disorders.
  Journal of autism and developmental disorders 2000 King BH
• Expert Consensus Guideline Series: Treatment of psychiatric and behavioral problems in mental retardation.
  American journal of mental retardation : AJMR 2000
• Carbamazepine reduces dopamine-mediated behavior in chronic neuroleptic-treated and untreated rats: implications for treatment of tardive dyskinesia and hyperdopaminergic states.
  Experimental and clinical psychopharmacology 2000 LaHoste GJ, Wigal T, King BH, Schuck SEB, Crinella FM, Swanson JM
• Pharmacologic management of psychiatric and behavioral symptoms in mental retardation.
  Child and adolescent psychiatric clinics of North America 2000 Madrid AL, State MW, King BH
• Practice parameters for the assessment and treatment of children, adolescents, and adults with mental retardation and comorbid mental disorders. American Academy of Child and Adolescent Psychiatry Working Group on Quality Issues.
  Journal of the American Academy of Child and Adolescent Psychiatry 1999 Szymanski L, King BH
• Summary of the Practice Parameters for the Assessment and Treatment of Children, Adolescents, and Adults with Mental Retardation and Comorbid Mental Disorders. American Academy of Child and Adolescent Psychiatry.
  Journal of the American Academy of Child and Adolescent Psychiatry 1999 Szymanski L, King BH
• Erratum: Association of an X-chromosome dodecamer insertional variant allele with mental retardation.
  Molecular Psychiatry 1999 R A Philibert, B H King, S Winfield, E H Cook, Y-H Lee, B Stubblefield, P Damschroder-Williams, C Dea, A Palotie, C Tengstrom, B M Martin, E I Ginns.
• Obsessive-compulsive symptoms in Prader-Willi and "Prader-Willi-Like" patients.
  Journal of the American Academy of Child and Adolescent Psychiatry 1999 State MW, Dykens EM, Rosner B, Martin A, King BH
• Cortical damage enhances pemoline-induced self-injurious behavior in prepubertal rats.
  Pharmacology, biochemistry, and behavior 1999 Cromwell HC, Levine MS, King BH
• Maladaptive behavior differences in Prader-Willi syndrome due to paternal deletion versus maternal uniparental disomy.
  American journal of mental retardation : AJMR 1999 Dykens EM, Cassidy SB, King BH
• Selective serotonin re-uptake inhibitors in intellectual disability
  Mental Retardation and Developmental Disabilities Research Reviews 1999 Racusin R, Kovner-Kline K, King BH
• Selective serotonin reuptake inhibitors in intellectual disability.
  Developmental Disabilities Research Reviews 1999 Robert Racusin, Kathleen Kovner-Kline, Bryan H. King
• Association of an X-chromosome dodecamer insertional variant allele with mental retardation.
  Molecular psychiatry 1998 Philibert RA, King BH, Winfield S, Cook EH, Lee YH, Stubblefield B, Damschroder-Williams P, Dea C, Palotie A, Tengstrom C, Martin BM, Ginns EI
• Molecular screening for proximal 15q abnormalities in a mentally retarded population.
  Journal of medical genetics 1998 Jacobsen J, King BH, Leventhal BL, Christian SL, Ledbetter DH, Cook EH
• Paroxetine treatment of aggression and self-injury in persons with mental retardation.
  American journal of mental retardation : AJMR 1998 Davanzo PA, Belin TR, Widawski MH, King BH
• Developmental aspects of stereotyped movement disorder
  Psychiatric Annals 1998 King BH, Krishnamurthy J
• Dopaminergic and glutamatergic interactions in the expression of self-injurious behavior.
  Developmental neuroscience 1998 King BH, Cromwell HC, Lee HT, Behrstock SP, Schmanke T, Maidment NT
• Open-label olanzapine treatment in five preadolescent children.
  Journal of child and adolescent psychopharmacology 1998 Krishnamoorthy J, King BH
• Proton MR spectroscopy in four patients with Lesch-Nyhan Disease
  American Journal of Neuroradiology 1998 Davanzo PA, Ke Y, King BH, Guze BH, McCracken J, Curran J, Thomas A
• Self-injurious behaviour in mental retardation
  Current Opinion in Psychiatry 1998 King BH, Lynn D
• Mental retardation: a review of the past 10 years. Part I.
  Journal of the American Academy of Child and Adolescent Psychiatry 1997 King BH, State MW, Shah B, Davanzo P, Dykens E
• Mental retardation: a review of the past 10 years. Part II.
  Journal of the American Academy of Child and Adolescent Psychiatry 1997 State MW, King BH, Dykens E
• Issues to consider in deaf and hard-of-hearing patients. The Committee on Disabilities of the Group for the Advancement of Psychiatry.
  American family physician 1997
• Eating themselves to death: have "personal rights" gone too far in treating people with Prader-Willi syndrome?
  Mental retardation 1997 Dykens EM, Goff BJ, Hodapp RM, Davis L, Devanzo P, Moss F, Halliday J, Shah B, State M, King B
• Child and learning disability psychopharmacology.
  Journal of psychopharmacology (Oxford, England) 1997
• Pemoline alters dopamine modulation of synaptic responses of neostriatal neurons in vitro.
  Developmental neuroscience 1997 Cromwell HC, King BH, Levine MS
• Pemoline produces ipsilateral turning behavior in unilateral 6-OHDA-lesioned rats.
  Progress in neuro-psychopharmacology & biological psychiatry 1996 Cromwell HC, Witte EA, Crawford CA, Ly HT, Maidment NT, King BH
• Buspirone treatment of aggression and self-injury in autistic and non autistic persons with severe mental retardation
  Developmental Brain Dysfunction 1996 King BH, Davanzo P
• Open trial lamotrigine in the treatment of self-injurious behavior in an adolescent with profound mental retardation.
  Journal of child and adolescent psychopharmacology 1996 Davanzo PA, King BH
• Dr. King and Colleagues Reply.
  American Journal of Psychiatry 1995 BRYAN H. KING, STEVEN R. FORNESS, JAMES T. MCCRACKEN
• Pretreatment with MK-801 inhibits pemoline-induced self-biting behavior in prepubertal rats.
  Developmental neuroscience 1995 King BH, Au D, Poland RE
• Psychiatric consultation in severe and profound mental retardation.
  The American journal of psychiatry 1994 King BH, DeAntonio C, McCracken JT, Forness SR, Ackerland V
• Simple versus Complex Conduct Disorders: Identification and Phenomenology.
  Behavioral Disorders 1994 Mary Margaret Kerr, Steven R. Forness, Kenneth A. Kavale, Bryan H. King, Connie Kasari
• Simple versus complex conduct disorders: Identification and phenomenology
  Behavioral Disorders 1994 Forness SR, Kavale K, King BH, Kasari C
• Self-injury by people with mental retardation: a compulsive behavior hypothesis.
  American journal of mental retardation : AJMR 1993 King BH
• Low-dose naltrexone inhibits pemoline-induced self-biting behavior in prepubertal rats.
  Journal of child and adolescent psychopharmacology 1993 King BH, Au D, Poland RE
• Hyperserotoninemia and antiserotonin antibodies in autism and other disorders.
  Journal of autism and developmental disorders 1992 Yuwiler A, Shih JC, Chen CH, Ritvo ER, Hanna G, Ellison GW, King BH
• Comments on self-injurious behaviour.
  The American journal of psychiatry 1991 King BH, Poland RE
• Deficiency in the opioid hypotheses of self-injurious behavior.
  American journal of mental retardation : AJMR 1991 King BH, McCracken JT, Poland RE
• 5-Hydroxytryptamine (5-HT)-induced shape change in human platelets determined by computerized data acquisition: correlation with [125I]-iodoLSD binding at 5-HT2 receptors.
  Blood coagulation & fibrinolysis : an international journal in haemostasis and thrombosis 1991 Brazell C, McClue SJ, Preston GC, King B, Stahl SM
• Fluoxetine reduced self-injurious behavior in an adolescent with mental retardation.
  Journal of child and adolescent psychopharmacology 1991 King BH
• Hypothesis: involvement of the serotonergic system in the clinical expression of monosymptomatic hypochondriasis.
  Pharmacopsychiatry 1990 King BH
• Proposals for the mechanism of action of convulsive therapy: a synthesis.
  Biological psychiatry 1990 King BH, Liston EH
• MK-212 increases rat plasma ACTH concentration by activation of the 5-HT1C receptor subtype.
  Neuroscience letters 1989 King BH, Brazell C, Dourish CT, Middlemiss DN
• Lies and liars: psychiatric aspects of prevarication.
  The American journal of psychiatry 1988 Ford CV, King BH, Hollender MH
• Pseudologia fantastica.
  Acta psychiatrica Scandinavica 1988 King BH, Ford CV
• Therapeutic sleep deprivation for depression in children.
  Journal of the American Academy of Child and Adolescent Psychiatry 1987 King BH, Baxter LR, Stuber M, Fish B
• Pseudologia Fantastica.
  American Journal of Psychiatry 1987 BRYAN H. KING, CHARLES V. FORD
• Pseudologia fantastica.
  The American journal of psychiatry 1987 King BH, Ford CV
• Developmental responses of the Drosophila melanogaster embryo to localized X irradiation.
  Radiation research 1982 King BH, Bryant PJ